Pharma Journalist -

AstraZeneca and Daiichi Sankyo have received notification of acceptance of the supplemental Biologics License Application (sBLA) of Enhertu (trastuzumab deruxtecan) for the treatment of…
Read More...

Bavarian Nordic A/S announced that the European Commission (EC) has extended the marketing authorization for the Company’s smallpox vaccine, IMVANEX to include protection from monkeypox…
Read More...

Sandoz announced that the US Food and Drug Administration (FDA) has accepted its biologics license application (BLA) for a proposed first-of-a-kind biosimilar natalizumab, developed by…
Read More...

Today, Ginkgo Bioworks — the leading horizontal platform for cell programming — and the biotechnology company Zymergen announced they have entered into a definitive agreement under…
Read More...

NewAmsterdam Pharma Holding B.V. a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases, and Frazier…
Read More...

Sangamo Therapeutics, Inc. announced that the European Commission (EC) has granted Orphan Medicinal Product Designation (OMPD) to TX200, a wholly-owned autologous Chimeric Antigen…
Read More...

Gilead Sciences, Inc. announced its upcoming contributions to the 24th International AIDS Conference (AIDS 2022). AIDS 2022 will be a hybrid conference, taking place in person in…
Read More...

As many Korean pharmaceutical manufacturers are currently attempting to develop new drugs for idiopathic pulmonary fibrosis, Daewoong Pharmaceutical's new medication DWN12088 has been…
Read More...

February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") entered a strategic collaboration with LiberoThera Co., Ltd (“LiberoThera”) to co-develop fully human…
Read More...

Artizan Biosciences, Inc. (“Artizan”), a biotechnology company creating gut exclusive microbial metalloprotease inhibitors (GEMMi), a new class of transformative precision therapeutics…
Read More...